Device manufacturer, as written on reports
Thoratec: medical device reports filed with FDA
78,106 reports name it as the manufacturer of the device involved, 2001–2026.
- 78,106
- reports naming it as manufacturer
- 0.3% of all MAUDE reports
- 7,189
- reports, 12 months to August 2026
- 7,763 in the 12 months before
- 32.9%
- classified as malfunction
- 62.3% across all reports
- 20%
- classified as death, as reported
- 0.9% across all reports
78,106 medical device reports received by FDA give Thoratec as the manufacturer of the device involved, 0.3% of the MAUDE database, from February 2001 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
7,189 reports arrived in the 12 months to August 2026, close to the 7,763 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (47.1%), malfunction (32.9%) and death (20%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| HeartMate 3 LVAS Implant Kit | Ventricular (assist) bypass | 13,403 | 626 | 38% |
| Thoratec HeartMate 3 LVAS Implant Kit | Ventricular (assist) bypass | 8,106 | 3,008 | 29.7% |
| HeartMate 3 Left Ventricular Assist System | Ventricular (assist) bypass | 5,842 | 122 | 18.6% |
| Thoratec HeartMate 3 System Controller | Ventricular (assist) bypass | 3,579 | 1,387 | 0% |
| HeartMate 3 System Controller | Ventricular (assist) bypass | 3,446 | 247 | 0.3% |
| Heartmate Mobile Power Unit Na | Ventricular (assist) bypass | 2,084 | 4 | 0.1% |
| Heartmate Mobile Power Unit N/A | Ventricular (assist) bypass | 1,227 | 519 | 0% |
| Thoratec Heartmate Lvas Implant Kit With Sealed Grafts | Ventricular (assist) bypass | 899 | 277 | 21.6% |
| HeartMate 3 VAD Modular Cable | Ventricular (assist) bypass | 745 | 95 | 0.1% |
| Thoratec HeartMate 3 VAD Modular Cable | Ventricular (assist) bypass | 655 | 251 | 0% |
| HeartMate Mobile Power Unit, EU | Ventricular (assist) bypass | 645 | 67 | 0.2% |
| Heartmate Xve Lvas | Ventricular (assist) bypass | 637 | 0 | 12.7% |
| Thoratec Heartmate System Monitor | Ventricular (assist) bypass | 298 | 9 | 0% |
| Heartmate Power Module | Ventricular (assist) bypass | 254 | 6 | 1.1% |
| Heartmate Power Module Eu | Ventricular (assist) bypass | 243 | 30 | 0% |
| Thoratec Ventricular Assist Device Vad System | Ventricular (assist) bypass | 239 | 0 | 11.3% |
| Heartmate Power Module N/A | Ventricular (assist) bypass | 225 | 74 | 0% |
| Heartmate | Ventricular (assist) bypass | 198 | 12 | 3.2% |
| Heartmate 3 Left Ventricular Assist System Europe | Ventricular (assist) bypass | 160 | 0 | 11.3% |
| HeartMate 3 | Ventricular (assist) bypass | 134 | 67 | 2.5% |
| CentriMag 2nd Generation Primary Console | Control, pump speed, cardiopulmonary bypass | 13 | 120 | 0.3% |
| Freestyle | Glucose dehydrogenase, glucose | 1 | 26 | 0.1% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| DSQ | Ventricular (assist) bypass | 77,841 | 99.7% |
| DSY | Prosthesis, vascular graft, of 6mm and greater diameter | 76 | 0.1% |
| DWA | Control, pump speed, cardiopulmonary bypass | 75 | 0.1% |
| KFM | Pump, blood, cardiopulmonary bypass, non-roller type | 45 | 0.1% |
| DTZ | Oxygenator, cardiopulmonary bypass | 27 | 0% |
| QNR | Blood pump for ecmo, long-term (> 6 hours) use | 26 | 0% |
| DWF | Catheter, cannula and tubing, vascular, cardiopulmonary bypass | 8 | 0% |
| DWS | Instruments, surgical, cardiovascular | 3 | 0% |
| LOZ | Artificial heart | 2 | 0% |
| NBE | Sealant, polymerizing | 2 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Thoratec reports
How many FDA device reports name Thoratec as manufacturer?
78,106 reports through August 2026, 7,189 of them in the latest 12 months.
Which of its brands appear most often?
HeartMate 3 LVAS Implant Kit (13,403), Thoratec HeartMate 3 LVAS Implant Kit (8,106), HeartMate 3 Left Ventricular Assist System (5,842), Thoratec HeartMate 3 System Controller (3,579) and HeartMate 3 System Controller (3,446).
Which device types does it report on?
ventricular (assist) bypass (99.7%), prosthesis, vascular graft, of 6mm and greater diameter (0.1%), control, pump speed, cardiopulmonary bypass (0.1%) and pump, blood, cardiopulmonary bypass, non-roller type (0.1%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.